Egypt vs Mauritius: Tuberculosis patients living with HIV receiving antiretroviral therapy
Egypt
12 patients
in 2021
Mauritius
12 patients
in 2021
Egypt rank
106th
Mauritius rank
106th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Egypt
- Mauritius
How they compare
Egypt currently reports 12 patients against 12 patients in Mauritius, a difference of 0 patients.
The two have swapped places 6 times across 17 shared years of data; in 2003 it was Mauritius ahead.
Egypt ranks 106th and Mauritius ranks 106th of 183 countries.
Across the 3 decades both report, Egypt averaged higher in 2 and Mauritius in 1.
Head to head by decade
| Decade | Egypt | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6 patients | 4.4 patients | 4.2 patients | Egypt |
| 2010s | 19.7 patients | 15.2 patients | 4.5 patients | Egypt |
| 2020s | 12 patients | 15 patients | 3 patients | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Egypt or Mauritius?
- Egypt, at 12 patients against 12 patients in Mauritius as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Egypt and Mauritius?
- 0 patients, with Egypt ahead.
- How many years of comparable data are there for Egypt and Mauritius?
- 17 years are reported by both, from 2003 to 2021.
- How do Egypt and Mauritius rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Egypt ranks 106th and Mauritius ranks 106th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.